This archive gathers more than 1,500 solutions-journalism stories tied to the United States — covering policy wins, community efforts, scientific advances, and social progress reported from across the country. Each article highlights what is working, who is driving change, and what results have followed.
Federal, state, and local government agencies in the United States and abroad that serve the unemployed can apply provide free access to Coursera’s courses—an offer that typically costs $399 per year—through September 30.
Scientists at Cornell University have engineered a new fishing net material that offers comparable strength to today’s solutions but can break down much more quickly when exposed to UV light.
A new report from the American Wind Energy Association, Iowa is now generating more than 10,000 megawatts of wind energy, accounting for more than 40% of the state’s electricity.
The new treatment is rapidly approaching human trials and hopes to have an FDA-approved treatment out the other end of the pipeline in 2-3 years.
Spoiler: True happiness comes not from setting ourselves above and apart from others, but from joining and serving our communities.
After four coal plants in Kentucky either retired or were retrofitted, local asthma-related hospitalizations dropped and individuals used their inhalers less frequently.
While the six-junction III-V technology underlying these new cells is likely too costly at this time to be put to use in everyday rooftop applications, the new cell has great potential for application in concentrated solar panel arrays.
Gov. Northam signed the Virginia Values Act, making it the first in the South and the 21st across the United States to pass anti-discrimination protections for the LGBTQ community.
“This shipment will help protect healthcare professionals working on the front lines against COVID-19 in the United States and demonstrates the strength of the U.S.-Vietnam partnership,” the U.S. embassy in Hanoi said.
“There’s never been a therapy for treatment-resistant depression that’s broken 55% remission rates in open-label testing,” the team says.
